BEIJING (Reuters) – Chinese COVID-19 vaccine developers Sinovac, Sinopharm and Cansino Bio have submitted application to join COVAX, a global schemed backed by the World Health Organization, foreign ministry spokeswoman Hua Chunying said on Wednesday.
(Reporting by Cate Cadell, editing by Louise Heavens)